22nd Century Group, Inc.
(NYSE Amex Equities : XXII)

( )
XXII After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
GILDGilead Sciences, Inc. -1.97%73.511.0%$1711.84m
AMGNAmgen, Inc. -0.45%218.211.3%$927.01m
REGNRegeneron Pharmaceuticals, Inc. 0.12%512.962.6%$847.29m
BIIBBiogen, Inc. 1.29%321.051.5%$816.11m
VRTXVertex Pharmaceuticals, Inc. -1.22%246.611.9%$649.45m
ILMNIllumina, Inc. 2.36%287.623.5%$503.42m
MRNAModerna, Inc. -1.73%31.860.0%$501.83m
ALXNAlexion Pharmaceuticals, Inc. -2.36%96.232.0%$301.82m
AAgilent Technologies, Inc. 2.14%78.331.6%$233.31m
INCYIncyte Corp. -1.07%86.812.5%$218.68m
EXASEXACT Sciences Corp. 1.04%67.0621.0%$184.03m
SGENSeattle Genetics, Inc. 0.54%120.326.1%$162.16m
BMRNBioMarin Pharmaceutical, Inc. -0.06%79.554.3%$150.47m
NVAXNovavax, Inc. -0.76%17.05114.7%$134.63m
IMMUImmunomedics, Inc. 6.57%19.6411.9%$129.09m

Company Profile

22nd Century Group, Inc. is a plant biotechnology company, which engages in the development of technology that will allow increasing or decreasing the level of nicotine and nicotinic alkaloids in tobacco plants and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding. Its products include X-22, modified risk cigarettes, spectrum government research cigarettes, magic 0 and magic 2, moonlight, red sun, variable nicotine-level research cigarettes, and verfola. The company was founded on September 12, 2005 and is headquartered in Clarence, NY.